Cawkwell Gail
Known title: Chief Medical OfficerCIK: 0001761167
Associated companies
Transaction History
| ACRS | ▲ Buy | Option Exercise | 15,000 | — | 7/1/2023 | View on chart |
| ACRS | ▼ Sell | Tax Withholding | 5,407 | $56K | 7/1/2023 | View on chart |
| ACRS | ▲ Buy | Option Exercise | 15,000 | — | 7/1/2023 | View on chart |
| ACRS | ▼ Sell | Tax Withholding | 5,407 | $56K | 7/1/2023 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
ACRS Not Highlighted in Recent Pre‑Market Moves
In the past week, pre‑market activity focused on large financial names and a list of 20 stocks, but Aclaris Therapeutics was not mentioned. The moves in big banks and other sectors could influence overall market sentiment, which may affect smaller biotech names like ACRS. No direct company news was reported, so the impact is limited at this time.
ACRS Not Highlighted in Recent Pre‑Market Moves. In the past week, pre‑market activity focused on large financial names and a list of 20 stocks, but Aclaris Therapeutics was not mentioned. The moves in big banks and other sectors could influence overall market sentiment, which may affect smaller biotech names like ACRS. No direct company news was reported, so the impact is limited at this time.